#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dementia Alzheimer's type Dermatitis atopic Asthma Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Leukocyte adhesion deficiency type I Epileptic encephalopathy Vulval cancer Sexually transmitted disease Scleroderma associated digital ulcer Huntington's disease Retinopathy of prematurity Uveitis Encephalopathy neonatal Factor VIII deficiency Dilated cardiomyopathy Biliary cancer metastatic Chronic lymphocytic leukaemia Glomerulonephritis Mantle cell lymphoma stage IV More trials…

    Learn about Rare Diseases

    Ewing’s sarcoma – Life with Disease Idiopathic inflammatory myopathy – Life with Disease Hepatoblastoma – Trials in Disease Small intestine leiomyosarcoma – Basic Information Pemphigus – Diagnostics Immunodeficiency congenital – Trials in Disease Rett syndrome – Life with Disease Glycogen storage disease type II – Diagnostics Hepatic angiosarcoma – Life with Disease Sarcoidosis – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Indacaterol Acetate Ly3437943 Sodium Azelastine Ephedrine Hydrochloride Vx-264 Balcinrenone Skin Autograft Tobevibart IBANDRONIC ACID Adalimumab Izaflortaucipir (18F) Dl-Alpha Tocopherol Acetate Dnth103 Etamsylate PETHIDINE HYDROCHLORIDE Chlorhexidine Dihydrochloride Naloxone MZE829 BI 456906 Nipocalimab More therapies…

    Learn about Your Condition

    Muscle hypertrophy Anal cancer stage II Bile duct adenocarcinoma Urethral valves Lung transplant rejection Vaginal infection Graft infection Obsessive-compulsive disorder Sinusitis bacterial Pneumothorax Head and neck cancer stage III Hepatic neoplasm Cholecystitis acute Aplasia pure red cell Herpes simplex meningitis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Institut Paoli-Calmettes Cancer Centre

Institut Paoli-Calmettes Cancer Centre

2jc Buaktunyq Dq Ssgxek Mromppllwua Bv 1ira Mulbkjajlw 1jlxce Fgszvj

Want to learn more about this study or check if you can participate? Contact us.

  • Study of Gedatolisib and Darolutamide Combination Treatment for Patients with Metastatic Castration-Resistant Prostate Cancer

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Hormone-refractory prostate cancer
    • Prostate cancer metastatic
    Investigated Drugs:
    • Gedatolisib
    • Darolutamide
    • Dexamethasone
    France Spain

  • Study Comparing CPX-351 and Chemotherapy for Patients with New Intermediate or High-Risk Acute Myeloid Leukemia

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Acute myeloid leukaemia
    Investigated Drugs:
    • Daunorubicin
    • Idarubicin
    • Cytarabine
    France

  • Study on MaaT033 to Prevent Complications in Patients with Blood Cancer Undergoing Stem Cell Transplantation

    Recruiting

    2 1
    Investigated Diseases:
    • Allogenic stem cell transplantation
    Investigated Drugs:
    • Allogeneic Faecal Microbiota, Pooled
    Belgium France Germany The Netherlands Spain

  • Study on UCART20x22 for Patients with Relapsed or Refractory B-cell Non-Hodgkin Lymphoma Using a Drug Combination

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • B-cell lymphoma
    • B-cell lymphoma refractory
    Investigated Drugs:
    • Aldesleukin
    • Alemtuzumab
    • Cyclophosphamide
    France Italy Spain

  • Study on Preventing Blood Clots in Patients with Advanced Germ Cell Tumors Using Cisplatin and a Drug Combination

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Testicular germ cell tumour
    Investigated Drugs:
    • Cisplatin
    • Dalteparin Sodium
    • Enoxaparin Sodium
    France

  • Study Comparing Clofarabine/Busulfan and Fludarabine/Busulfan for Adults with Acute Myeloid Leukemia Eligible for Stem Cell Transplantation

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Clofarabine
    • Fludrocortisone Acetate
    • Anti-T Lymphocyte Immunoglobulin For Human Use, Rabbit
    France

  • Study on Durvalumab for Patients with High-Risk Endometrial Cancer After Surgery

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Endometrial cancer
    Investigated Drugs:
    • Durvalumab
    Belgium Czechia France Germany Italy The Netherlands

  • Study on the Effectiveness of ADT with or without Darolutamide in Men with Newly Diagnosed Metastatic Prostate Cancer and Limited Functional Ability

    Recruiting

    3 1 1
    Investigated Diseases:
    • Prostate cancer metastatic
    Investigated Drugs:
    • Darolutamide
    Belgium France Germany Ireland Italy The Netherlands +4

  • Study of Camizestrant for Patients with ER+/HER2- Early Breast Cancer After 2 Years of Standard Endocrine Therapy

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Goserelin
    • Leuprorelin
    • Triptorelin
    Austria Belgium Bulgaria Czechia France Germany +8

  • Study on Improving Treatment for Young Adults with Poor-Prognosis Non-Seminomatous Germ-Cell Tumors Using Paclitaxel and Drug Combination

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Lenograstim
    • Bleomycin Sulfate
    • Ifosfamide
    France
Previous Page
1 … 14 15 16 17 18 … 42
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!